Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma
Lili Zhang, Xiaofang Luo, Sen Qiao
British Journal of Cancer (2022) Vol. 127, Iss. 1, pp. 30-42
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 176
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
Yun-zhang Dai, Yong-da Liu, Jie Li, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 91
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 59
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
Huanxiang Chen, Hongyang Liu, Chenxing Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 7
N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis
Bao Yuan, Jin Zhou
PeerJ (2023) Vol. 11, pp. e14591-e14591
Open Access | Times Cited: 13
Crosstalk between m6A regulators and mRNA during cancer progression
Xiaodong Niu, Yuan Yang, Yanming Ren, et al.
Oncogene (2022) Vol. 41, Iss. 39, pp. 4407-4419
Closed Access | Times Cited: 19
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
The role of RNA-modifying proteins in renal cell carcinoma
Muna A. Ali, Khuloud Bajbouj, Iman M. Talaat, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas
Ok‐Hwan Lee, Li Zhuang, Boyi Gan
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 4
N-methyladenosine enhances the expression of TGF-β-SMAD signaling family to inhibit cell growth and promote cell metastasis
Bo Peng, Shuwen Cheng, H. Wang, et al.
Cancer Letters (2024) Vol. 603, pp. 217195-217195
Closed Access | Times Cited: 4
METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
Zhuonan Liu, Tianshui Sun, Zhe Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Identification and Characterization of the RNA Modifying Factors PUS7 and WTAP as Key Components for the Control of Tumor Biological Processes in Renal Cell Carcinomas
Tim Hohmann, Urszula Grabiec, Faramarz Dehghani, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 266-266
Open Access
N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential
Yuting Sun, De Jin, Ziwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194967-194967
Open Access | Times Cited: 10
Liquid–liquid phase separation in diseases
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
Jie Liu, Xinyu Gu, Zhenjie Guan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
N6-methyladenosine methylation in kidney injury
Qimeng Wang, Xiaoting Fan, Qinghao Sheng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
m6A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis
Huamei Wei, Jinhun Yang, Rongzhou Lu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Nucleic acid and protein methylation modification in renal diseases
Juan Jin, Xuemei Liu, Wei Shao, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 661-673
Closed Access | Times Cited: 6
METTL16 in human diseases: What should we do next?
Hui Zhang, Mengqi Yin, Hua Huang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
METTL14-Mediate the Biological Effects of EMT in Bladder Cancer Cells by Methylating SOX4 mRNA with m6A
Mengliang Xie, Huantao Zhang
Indian Journal of Pharmaceutical Education and Research (2024) Vol. 58, Iss. 3, pp. 814-821
Open Access | Times Cited: 1
SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma
Kaihong Wang, Xinpeng Chen, Yifu Liu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 7, pp. 3536-3555
Open Access | Times Cited: 1
Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights
Ângela Alves, Rui Medeiros, Ana Luísa Teixeira, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189165-189165
Open Access | Times Cited: 1
The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression
Wenhao Zhu, Renshan Zhao, Xiaomin Guan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top